Issn Print: 1556-0864
Publication Date: 2017/11/01
Cases ofALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy
Deepa Rangachari; Xiuning Le; Meghan Shea; Mark S. Huberman; Paul A. VanderLaan; Susumu S. Kobayashi; Daniel B. Costa
Author Information: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.